Why Behavior Alone Is No Longer Enough: The Rise of Brain Data as a New Vital Sign

For decades, clinicians and researchers have relied heavily on behavioral performance to evaluate brain health. Reaction time, memory recall, symptom checklists, and task accuracy have been the gold standards. But what if two people perform the same on a test, while one brain is working twice as hard to achieve it? How can clinicians assess the neural landscape dictating performance?

At a recent discussion round, Neuronic hosted Ryan Field, PhD and CEO of Kernel, a neurotech company founded by biohacker Bryan Johnson. In Field’s presentation, one message stood out clearly:

We cannot improve what we cannot measure. Direct brain data is becoming the next vital sign.

And that shift has major implications for cognitive assessment, mental health, and preventative brain care.

The Hidden Problem With Behavior-Only Cognitive Testing

Traditional cognitive assessments tell us what someone can do but often fail to show how efficiently the brain is doing it.

This creates three major blind spots:

1. Compensation masking impairment - People can maintain behavioral performance for a certain time while their neural efficiency declines.
2. Early changes go undetected - Subtle brain dysfunction may appear years before test scores drop.
3. Treatment effects are hard to personalize - We can’t see who is neurologically responding versus just behaviorally improving.

Kernel Flow:

Light-Based Measurement for Real-Time Brain Activity

After years of sifting through the latest breakthroughs in brain assessment technology, Kernel landed on time-domain near-infrared spectroscopy (TD-NIRS) - a technique that uses pulses of near-infrared light to measure changes in brain oxygenation, similar to the signals captured in fMRI.

Kernel’s current system, Kernel Flow, combines:

• Dense optical sensors for monitoring oxygenated (HbO) and deoxygenated (HHb) hemoglobin
• Integrated EEG electrodes for fast electrical activity
• Cloud-based AI/ML processing to convert raw signals into clear, actionable cognitive scores

This makes Flow a unique hybrid: portable like consumer wearables, yet scientifically validated like research-grade neuroimaging tools. This technology can help clinicians more accurately assess the brain health of their clients beyond behavioural metrics.

The Alcohol Study That Exposed “Hidden” Cognitive Impairment

In one of Kernel’s most striking early studies, healthy participants completed inhibitory control tasks under three conditions:

• Placebo (0.00% BAC)
• Low-dose alcohol (BAC 0.04%)
• Moderate-dose alcohol (BAC 0.08%)

*BAC = target Blood Alcohol Concentration

Behaviorally, performance appeared nearly identical between placebo and low-dose alcohol.

But when Kernel measured brain oxygenation and neural workload, the story changed completely.

The brain showed dose-dependent impairment across all three levels - even when behavior alone suggested “no difference.” This is yet another example of how behavioural metrics are not cutting it when it comes to assessing brain health and functionality.

The insight:

The brain was already struggling before behavior ever showed it.

For clinicians, this raises a thought-provoking question:

How many of our patients look fine behaviorally while their brains are actually under strain?

From Diagnosis to Prediction: Brain Data That Anticipates Outcomes

Another major inflection point came from Kernel’s depression research that has not yet been formally published.

Using their optical brain-measurement system, the team analyzed pre-treatment brain activity in patients undergoing TMS (transcranial magnetic stimulation). At the midpoint of the study:

• They achieved over 90% accuracy in predicting who would respond to treatment before therapy even began.

The implication for clinicians:

Brain data may soon help determine:

• Who is likely to benefit from specific interventions
• Who may need alternate strategies
• How to avoid months of trial-and-error care

Further Scientific Validation

Motor Cortex, Reliability, and Mild Cognitive Impairment Studies

Beyond assessing cognitive impairment in alcohol use, Kernel also has many other studies to verify the validity of their TD-NIRS technology:

✔ Motor Cortex Mapping (2022)

Finger-tapping tasks showed precise activation patterns in the motor cortex, closely matching what fMRI detects.

✔ Test-retest reliability (2023)

Ensuring the system can track real changes in brain function - not measurement noise - was essential.

✔ Mild Cognitive Impairment (2024)

Kernel identified distinct neural signatures separating MCI patients from age-matched controls, suggesting potential for early detection frameworks (not diagnostic, but pattern-based).

‍

Brain Age vs Cognition Tracking

Field offered one of the most useful analogies of the entire talk:

• Brain Age ≈ The Scale
• Cognition Tracker ≈ The DEXA Scan

Building on this analogy, Kernel has shifted toward the wellness and performance space with two new products:

1. Brain Age (“The Scale”)

A 7-minute passive scan of resting brain function. It provides:

• A single functional brain-age score
• Longitudinal tracking across weeks and months
• Sensitivity to sleep, stress, travel, exercise, and lifestyle

It answers: How is your brain functioning today, globally?

‍

1. Cognition Tracker (“The DEXA Scan”)

A task-based assessment measuring both:

• Behavioral performance
• Real-time brain activity during task execution

It maps five key domains:

• Attention
• Executive function
• Memory & learning
• Language
• Perceptual-motor function

It answers: Where is this brain struggling or excelling functionally?

‍

Why This Matters for Clinicians & Brain-Health Providers

This shift from reliance on behavioural metrics to adding objective measures opens a new category of care:

• Earlier identification of cognitive strain
• Objective tracking of intervention response
• Longitudinal monitoring of brain efficiency
• Distinguishing compensation from recovery
• Personalized mental health pathways
• A bridge between wellness and clinical neuroscience

Instead of waiting for:

• Symptom escalation
• Test score decline
• Functional impairment

We can now begin measuring brain trajectory itself.

Conclusion: The Brain Is Becoming a Standard Vital Sign

The most important shift emerging from Kernel’s work is not a headset, a score, or a dashboard.

It’s this:

We are entering the era where brain function itself becomes a routinely monitored vital sign - just like blood pressure, heart rate, and glucose.

When we stop relying on behavior alone and begin tracking how the brain is truly functioning, we unlock:

• Earlier insight
• Better treatment personalization
• Smarter preventative strategies
• And a more complete understanding of cognitive health across the lifespan

The future of brain care will not be built on questionnaires alone. It will be built on direct, objective, longitudinal brain data.

And that shift is already underway.

‍